← FDA Drug Approvals (Drugs@FDA)

EMERPHED

NDA · New Drug Application · Sponsor: NEXUS · Approved 2020-04-17

Drug application

FDA Application #

NDA213407

Application type

New Drug Application

Brand name

EMERPHED

Generic name

EPHEDRINE SULFATE

Active ingredients

EPHEDRINE SULFATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

NEXUS

Manufacturer

Nexus Pharamaceuticals Inc.

First approval

2020-04-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown